Welcome to our dedicated page for Helen Of Troy SEC filings (Ticker: HELE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Helen of Troy Limited (NASDAQ: HELE) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, strategy, and risks as a global consumer products company. These SEC filings cover its Home & Outdoor and Beauty & Wellness segments and its portfolio of brands, which includes OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June.
On this page, investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which present consolidated and segment‑level financial statements, management’s discussion and analysis, and detailed risk factors. These filings explain how factors such as tariffs, retailer behavior, competition, and international market conditions affect Helen of Troy’s reported net sales, margins, and cash flows, and they reconcile GAAP results to non‑GAAP measures like adjusted operating income, adjusted diluted EPS, and adjusted EBITDA.
Current reports on Form 8‑K document material events, including amendments to the company’s credit agreement, executive and director appointments or departures, quarterly earnings releases furnished under Item 2.02, and shareholder meeting results. For example, recent 8‑Ks describe a first amendment to the company’s revolving credit facility that adjusts the commitment size, leverage‑based pricing, and financial covenants, as well as the approval of the Helen of Troy Limited 2025 Stock Incentive Plan and the appointment of a new Chief Executive Officer.
The company’s proxy statements on Schedule 14A provide additional detail on governance, director elections, executive compensation, stock incentive plans, and shareholder voting outcomes. These documents outline the Elevate for Growth Strategy, Project Pegasus restructuring efforts, stock ownership guidelines, and the structure of cash and equity incentives for senior leaders.
Stock Titan enhances access to these filings with AI‑powered summaries that highlight key points from lengthy 10‑K, 10‑Q, and 8‑K documents, helping readers quickly understand changes in leverage covenants, impairment charges, segment performance, and compensation arrangements. Real‑time updates from EDGAR ensure that new Helen of Troy filings, including any Form 4 insider transaction reports or future registration statements, appear promptly, while AI‑generated overviews make complex regulatory language easier to interpret.
CASE THURMAN K reported acquisition or exercise transactions in this Form 4 filing.
Helen of Troy Ltd director Thurman K. Case received a grant of 1,429 common shares on March 2, 2026 as a restricted stock award. The award was priced at $0.00 per share, indicating it was a compensation grant rather than an open-market purchase. The restricted stock vested immediately and includes a tax-offset right that provides cash to cover certain tax liabilities arising from the vesting event. Following this grant, Case directly owns a total of 10,725 common shares.
CARSON VINCENT D reported acquisition or exercise transactions in this Form 4 filing.
Helen of Troy Ltd director Vincent D. Carson received a grant of 1,429 common shares as restricted stock that vested immediately at no stated price per share. Following this award, he directly holds 19,844 common shares. The grant includes a tax-offset right to help cover related tax liabilities in cash.
Berry Krista reported acquisition or exercise transactions in this Form 4 filing.
HELEN OF TROY LTD director Krista Berry received an equity award in the form of company stock. On the reported date, she was granted 1,429 common shares at a price of $0.00 per share as a restricted stock award. According to the footnote, the restricted stock vested immediately and is paired with a tax-offset right that provides cash to cover certain tax liabilities triggered by the vesting. After this grant, Berry directly holds a total of 10,547 common shares.
Woody Darren G reported acquisition or exercise transactions in this Form 4 filing.
Helen of Troy Ltd director Darren G. Woody received an equity grant of 1,429 common shares as restricted stock on March 2, 2026. The award was granted at no cash cost per share and vested immediately. Following this grant, his directly held common shares increased to 14,140. The filing also notes an additional 10 common shares held indirectly through his spouse. The restricted stock is accompanied by a tax-offset right that provides a cash amount to cover certain tax liabilities arising from the vesting event.
Helen of Troy Ltd director Beryl Raff received a new stock award. On the reported date, she acquired 1,429 common shares as a grant of restricted stock at no purchase price. After this award, she directly holds a total of 12,860 common shares.
The restricted stock vested immediately and is paired with a tax-offset right. This right provides a cash amount upon vesting to cover certain tax liabilities arising from the grant, allowing the director to meet tax obligations without selling the awarded shares.
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 1,526,957 shares of Helen of Troy Ltd common stock, representing 6.63% of the outstanding class. Vanguard has shared voting power over 232,166 shares and shared dispositive power over all 1,526,957 shares, with no sole voting or dispositive authority.
Vanguard explains that an internal realignment on January 12, 2026 shifted portfolio management and proxy voting away from The Vanguard Group, Inc., and it anticipates certain subsidiaries or business divisions will report ownership separately. The filing states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Helen of Troy.
BlackRock, Inc. reports beneficial ownership of 1,607,055 common shares of Helen of Troy Limited, representing 7.0% of the company’s common stock. BlackRock has sole voting power over 1,567,065 shares and sole dispositive power over 1,607,055 shares, with no shared voting or dispositive power. The filing notes that various persons have rights to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Helen of Troy.
BlackRock, Inc. reports beneficial ownership of 1,607,055 common shares of Helen of Troy Limited, representing 7.0% of the company’s common stock. BlackRock has sole voting power over 1,567,065 shares and sole dispositive power over 1,607,055 shares, with no shared voting or dispositive power. The filing notes that various persons have rights to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Helen of Troy.
Helen of Troy Limited reported a sharp downturn for the quarter and nine months ended November 30, 2025, driven by large non-cash write-downs. Quarterly net sales were $512.8 million, slightly below $530.7 million a year earlier, but the company posted a net loss of $84.1 million versus prior-year net income of $49.6 million. For the first nine months, sales were $1.32 billion while net loss reached $843.4 million compared to income of $72.8 million in the prior-year period.
The swing into loss reflects $806.7 million of pre-tax asset impairment charges year-to-date, including significant goodwill and trademark write-downs across the Home & Outdoor and Beauty & Wellness segments. Goodwill fell from $1.18 billion to $530.2 million, and other intangible assets decreased from $566.8 million to $398.5 million. Despite this, operating cash flow remained positive at $59.8 million, and long-term debt stood at $892.4 million with cash of $27.1 million.
The company completed the acquisition of Olive & June for $224.7 million in initial cash consideration plus up to $15.0 million of contingent payments tied to 2025–2027 EBITDA. It also amended its $1.5 billion credit agreement, reducing the revolver to $750.0 million and temporarily allowing a higher maximum leverage ratio of up to 4.50x. In legal matters, Helen of Troy received a favorable Federal Circuit decision invalidating Brita LP’s asserted patent claims, and Brita has moved to dismiss the related district court case.
Helen of Troy Limited furnished an update on its business by issuing a press release with results for the third quarter of fiscal 2026. The company is providing this press release as an exhibit to this report and also making it available on its investor relations website.
The company includes forward-looking statements about future sales, expenses, earnings per share and operating results, and cautions that actual outcomes may differ due to a wide range of business, economic, operational, cybersecurity, regulatory, tax, and supply chain risks described in its prior annual report and other filings. The press release also uses certain non-GAAP financial measures and provides reconciliations to the most comparable GAAP figures, while noting that these adjusted metrics have limitations and should not be viewed as a substitute for GAAP results.
Helen of Troy Limited entered into a First Amendment to its existing Credit Agreement with Bank of America and other lenders. The amendment reduces the revolving credit facility commitment from $1.0 billion to $750.0 million and adjusts interest rate pricing for higher leverage levels, so that when the Net Leverage Ratio is at or above 4.00 to 1.00, borrowings bear floating interest at the Base Rate plus a 1.375% margin or Term SOFR plus a 2.375% margin, with an additional 0.10% credit spread for Term SOFR.
The amendment also revises key financial covenants. The interest coverage test now uses a Consolidated EBITDA measure in the numerator, and the maximum permitted Leverage Ratio steps down over time, from 4.50 to 1.00 through August 31, 2026 to 3.50 to 1.00 from August 31, 2027 onward. Subject to conditions for a Qualified Acquisition, the borrower may elect a Leverage Holiday after August 31, 2027. Certain investment and indebtedness baskets are reduced until August 31, 2027, while customary events of default remain in place.